Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

Authors

• Yonas E. Geda, Mayo Clinic Scottsdale-Phoenix, ArizonaFollow
• Lon S. Schneider, University of Southern California
• Laura N. Gitlin, Johns Hopkins University
• David S. Miller, Bracket
• Gwenn S. Smith, Johns Hopkins School of Medicine
• Joanne Bell, Pfizer Global Research and Development
• Jovier Evans, National Institute of Mental Health (NIMH)
• Michael Lee, University of Minnesota Twin Cities
• Anton Porsteinsson, University of Rochester School of Medicine and Dentistry
• Krista L. Lanctôt, Sunnybrook Health Sciences Centre
• Paul B. Rosenberg, Johns Hopkins School of Medicine
• David L. Sultzer, David Geffen School of Medicine at UCLA
• Paul T. Francis, King's College London
• Henry Brodaty, UNSW Medicine
• Prasad P. Padala, Geriatric Research Education and Clinical Center
• Chiadikaobi U. Onyike, Johns Hopkins School of Medicine
• Luis Agüera Ortiz, Centro de Investigación Biomédica En Red de Salud Mental
• Sonia Ancoli-Israel, Department of Psychiatry
• Donald L. Bliwise, Wesley Woods Health Center
• Jennifer L. Martin, David Geffen School of Medicine at UCLA
• Michael V. Vitiello, University of Washington, Seattle
• Kristine Yaffe, University of California, San Francisco
• Phyllis C. Zee, Northwestern University Feinberg School of Medicine
• Nathan Herrmann, Sunnybrook Health Sciences Centre
• Robert A. Sweet, University of Pittsburgh
• Clive Ballard, King's College London
• Ni A. Khin, Center for Drug Evaluation and Research
• Cara Alfaro, Center for Drug Evaluation and Research
• Patrick S. Murray, University of Pittsburgh
• Susan Schultz, University of Iowa Carver College of Medicine
• Constantine G. Lyketsos, Johns Hopkins School of Medicine

Document Type

Article

Abstract

Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are widespread and disabling. This has been known since Dr. Alois Alzheimer's first case, Frau Auguste D., presented with emotional distress and delusions of infidelity/excessive jealousy, followed by cognitive symptoms. Being cognizant of this, in 2010 the Alzheimer's Association convened a research roundtable on the topic of NPS in AD. A major outcome of the roundtable was the founding of a Professional Interest Area (PIA) within the International Society to Advance Alzheimer's Research and Treatment (ISTAART). The NPS-PIA has prepared a series of documents that are intended to summarize the literature and provide more detailed specific recommendations for NPS research. This overview paper is the first of these living documents that will be updated periodically as the science advances. The overview is followed by syndrome-specific synthetic reviews and recommendations prepared by NPS-PIA workgroups on depression, apathy, sleep, agitation, and psychosis. © 2013 The Alzheimer¢s Association. All rights reserved.

Publication Date

1-1-2013

Publication Title

Alzheimer's and Dementia

ISSN

15525260

Volume

9

Issue

5

First Page

602

Last Page

608

PubMed ID

23562430

Digital Object Identifier (DOI)

10.1016/j.jalz.2012.12.001

Recommended Citation

Geda, Yonas E.; Schneider, Lon S.; Gitlin, Laura N.; Miller, David S.; Smith, Gwenn S.; Bell, Joanne; Evans, Jovier; Lee, Michael; Porsteinsson, Anton; Lanctôt, Krista L.; Rosenberg, Paul B.; Sultzer, David L.; Francis, Paul T.; Brodaty, Henry; Padala, Prasad P.; Onyike, Chiadikaobi U.; Ortiz, Luis Agüera; Ancoli-Israel, Sonia; Bliwise, Donald L.; Martin, Jennifer L.; Vitiello, Michael V.; Yaffe, Kristine; Zee, Phyllis C.; Herrmann, Nathan; Sweet, Robert A.; Ballard, Clive; Khin, Ni A.; Alfaro, Cara; Murray, Patrick S.; Schultz, Susan; and Lyketsos, Constantine G., "Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future" (2013). Neurology. 409.
https://scholar.barrowneuro.org/neurology/409